Ligand-specific regulation of a binary enhancer code dictating cellular senescence

T Thomas Suter (Cellular and Molecular Medicine, Department of Medicine, University of California San Diego) M Meyer J. Friedman (Cellular and Molecular Medicine, Department of Medicine, University of California San Diego) C Cagdas Tazearslan (Department of Genetics, Albert Einstein College of Medicine) D Daria Merkurjev (Cellular and Molecular Medicine, Department of Medicine, University of California San Diego) K Kenny Ohgi (Cellular and Molecular Medicine, Department of Medicine, University of California San Diego) D Dario Meluzzi (Cellular and Molecular Medicine, Department of Medicine, University of California San Diego) M Michael G. Rosenfeld (Cellular and Molecular Medicine, Department of Medicine, University of California San Diego) Y Yousin Suh

Abstract

Cellular senescence, a major contributor to aging and age-related pathologies, is characterized by irreversible proliferative arrest and a disease-linked, proinflammatory profile known as the Senescence Associated Secretory Phenotype (SASP). A critical unanswered question is whether these properties are regulated by specific enhancer subsets, potentially licensing strategies that selectively block deleterious SASP components. Here, we identify two functionally distinct and independently regulated enhancer programs underlying senescence that are controlled by different TGF-β family ligands. Whereas Activin A stimulates recruitment of nuclear factor IA/C (NFIA/C) and SMAD2/3 transcription factors to an enhancer network that induces proliferation arrest, TGF-β2 promotes SMAD2/3-mediated suppression of a p65-dependent enhancer cohort driving the SASP. We have also uncovered reciprocal SMAD2/3-super-enhancer-regulated feedback loops that govern expression of the TGF-β2 ( TGFB2) and Activin A ( INHBA ) transcription units, both of which are significantly up-regulated in replicative senescence. The characteristic enhancer usage and transcriptional landscape of high-passage senescent cells are sensitive to rapamycin treatment, discontinuation of which results in robust but selective senescent enhancer activation and exacerbation of the SASP. Collectively, this study uncovers separable enhancer programs and their key constituent transcription factors that contribute to the canonical features of cellular senescence, potentially informing the development of SASP-targeted therapies.

Article Details

Volume / Issue Vol. 122, Issue 24
Published June 17, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (8)

T

Thomas Suter

Cellular and Molecular Medicine, Department of Medicine, University of California San Diego

M

Meyer J. Friedman

Cellular and Molecular Medicine, Department of Medicine, University of California San Diego

C

Cagdas Tazearslan

Department of Genetics, Albert Einstein College of Medicine

D

Daria Merkurjev

Cellular and Molecular Medicine, Department of Medicine, University of California San Diego

K

Kenny Ohgi

Cellular and Molecular Medicine, Department of Medicine, University of California San Diego

D

Dario Meluzzi

Cellular and Molecular Medicine, Department of Medicine, University of California San Diego

M

Michael G. Rosenfeld

Cellular and Molecular Medicine, Department of Medicine, University of California San Diego

Y

Yousin Suh